Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Collaborative privacy-preserving analysis of oncological data using multiparty homomorphic encryption.
Geva R, Gusev A, Polyakov Y, Liram L, Rosolio O, Alexandru A, Genise N, Blatt M, Duchin Z, Waissengrin B, Mirelman D, Bukstein F, Blumenthal DT, Wolf I, Pelles-Avraham S, Schaffer T, Lavi LA, Micciancio D, Vaikuntanathan V, Badawi AA, Goldwasser S. Geva R, et al. Among authors: waissengrin b. Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2304415120. doi: 10.1073/pnas.2304415120. Epub 2023 Aug 7. Proc Natl Acad Sci U S A. 2023. PMID: 37549296 Free PMC article.
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
Waissengrin B, Zahavi T, Salmon-Divon M, Goldberg A, Wolf I, Rubinek T, Winkler T, Farkash O, Grinshpun A, Zubkov A, Khatib M, Shachar SS, Keren N, Carmi-Levy I, Ben-David U, Sonnenblick A. Waissengrin B, et al. ESMO Open. 2022 Dec;7(6):100648. doi: 10.1016/j.esmoop.2022.100648. Epub 2022 Nov 30. ESMO Open. 2022. PMID: 36462463 Free PMC article.
First-Line Efficacy of Anti-HER2 Treatments in Previously Treated HER2-Positive Metastatic Breast Cancer Patients: A Retrospective Observational Study Investigating the Efficacy of Re-Exposure to Anti-HER2 Therapy for HER2-Positive Metastatic Breast Cancer Patients in Comparison with Naïve Patients.
Waissengrin B, Levin R, Wolf I, Shachar E, Sonnenblick A. Waissengrin B, et al. Breast Care (Basel). 2022 Apr;17(2):146-152. doi: 10.1159/000516936. Epub 2021 Jul 7. Breast Care (Basel). 2022. PMID: 35707178 Free PMC article.
Less Is More: Polypharmacy at the End of Life.
Barak R, Waissengrin B, Wolf I. Barak R, et al. Among authors: waissengrin b. Isr Med Assoc J. 2021 Jul;23(7):452-453. Isr Med Assoc J. 2021. PMID: 34251131 Free article. No abstract available.
22 results